{
    "clinical_study": {
        "@rank": "375",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 14, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04337047"
        },
        "id_info": {
            "org_study_id": "WefightDistress20",
            "nct_id": "NCT04337047"
        },
        "brief_title": "Assessment of Distress in Crisis Situations During COVID-19",
        "official_title": "Assessment of Distress in Crisis Situations During COVID-19",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wefight",
                "agency_class": "Industry"
            }
        },
        "source": "Wefight",
        "oversight_info": {
            "has_dmc": "Yes",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "There are many scales for screening or assessing the impact of a disease. These scales are\n      generally used to diagnose or assess the severity of a disease and are carried out at the\n      request of a physician by the patient. Conversational agents could make it possible to\n      administer these questionnaires remotely, analyse them and use the results on a large scale,\n      without prior medical intervention.\n\n      The main objective of this study is to quantify and qualify the distress of a large\n      population in times of pandemic crisis."
        },
        "detailed_description": {
            "textblock": "The Peritraumatic Distress Inventory is the standard tool designed to assess distress in\n      times of crisis. It consists of 13 questions.\n\n      Questions will be submitted to the participants from the Vik chatbot. Responses will be\n      analysed and compared according to the demographics and pathologies encountered."
        },
        "overall_status": "Enrolling by invitation",
        "start_date": {
            "@type": "Actual",
            "#text": "March 31, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "May 31, 2020"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "April 30, 2020"
        },
        "study_type": "Observational",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Cohort",
            "time_perspective": "Prospective"
        },
        "primary_outcome": {
            "measure": "quantify and qualify distress over a large population in times of pandemic crisis.",
            "time_frame": "1 month"
        },
        "secondary_outcome": {
            "measure": "qualify demographic data vs distress over a large population in times of pandemic crisis.",
            "time_frame": "1 month"
        },
        "number_of_groups": "4",
        "enrollment": {
            "@type": "Actual",
            "#text": "2000"
        },
        "condition": "Stress, Psychological",
        "arm_group": [
            {
                "arm_group_label": "Vik sein",
                "description": "Vik sein users"
            },
            {
                "arm_group_label": "Vik asthme",
                "description": "Vik asthme users"
            },
            {
                "arm_group_label": "Vik migraine",
                "description": "Vik migraine users"
            },
            {
                "arm_group_label": "Vik depression",
                "description": "Vik depression users"
            }
        ],
        "intervention": {
            "intervention_type": "Other",
            "intervention_name": "questionnaire assesment",
            "description": "questionnaire assesment",
            "arm_group_label": [
                "Vik asthme",
                "Vik depression",
                "Vik migraine",
                "Vik sein"
            ]
        },
        "eligibility": {
            "study_pop": {
                "textblock": "Vik's users in France"
            },
            "sampling_method": "Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years old\n\n               -  Collection of the subject's non-opposition\n\n               -  Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression\n\n        Exclusion Criteria:\n\n          -  Patient unable to formulate non-opposition"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "N/A",
            "healthy_volunteers": "Accepts Healthy Volunteers"
        },
        "location": {
            "facility": {
                "name": "Wefight",
                "address": {
                    "city": "Montpellier",
                    "zip": "34000",
                    "country": "France"
                }
            }
        },
        "location_countries": {
            "country": "France"
        },
        "verification_date": "April 2020",
        "study_first_submitted": "April 3, 2020",
        "study_first_submitted_qc": "April 3, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "April 7, 2020"
        },
        "last_update_submitted": "April 3, 2020",
        "last_update_submitted_qc": "April 3, 2020",
        "last_update_posted": {
            "@type": "Actual",
            "#text": "April 7, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Principal Investigator",
            "investigator_affiliation": "Wefight",
            "investigator_full_name": "benjamin CHAIX",
            "investigator_title": "Chief Science Officer"
        },
        "condition_browse": {
            "mesh_term": "Stress, Psychological"
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}